-
EP2597086
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2597086
| EP2597086 - CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS AS ANDROGEN RECEPTOR ANTAGONISTS, ANTI-CANCER AGENT, METHOD FOR PRODUCING AND USING SAME [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 12.12.2014 Database last updated on 19.10.2024 | Most recent event Tooltip | 12.12.2014 | Application deemed to be withdrawn | published on 14.01.2015 [2015/03] | Applicant(s) | For all designated states Ivachtchenko, Alexandre Vasilievich 2874 Calle Rancho Vista Encinitas, CA 92024 / RU | For all designated states Ivashchenko, Andrey Alexandrovich ul. Abramtsevskaya, 4/2-27 Moscow 127576 / RU | For all designated states Savchuk, Nikolay Filippovich ul. Nametkina 9-35 Moscow 117420 / RU | [2013/22] | Inventor(s) | 01 /
MITKIN, Oleg Dmitrievich Kurkinskoe shosse 20-62 Khimki Moskovskaya obl. 141400 / RU | [2013/22] | Representative(s) | Zellentin & Partner mbB Patentanwälte Rubensstraße 30 67061 Ludwigshafen / DE | [N/P] |
| Former [2013/22] | Patentanwälte Zellentin & Partner Rubensstrasse 30 67061 Ludwigshafen / DE | Application number, filing date | 11809933.2 | 01.07.2011 | WO2011RU00476 | Priority number, date | RU20100130618 | 22.07.2010 Original published format: RU 2010130618 | [2013/22] | Filing language | RU | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2012011840 | Date: | 26.01.2012 | Language: | RU | [2012/04] | Type: | A1 Application with search report | No.: | EP2597086 | Date: | 29.05.2013 | Language: | EN | [2013/22] | Search report(s) | International search report - published on: | RU | 26.01.2012 | (Supplementary) European search report - dispatched on: | EP | 09.10.2013 | Classification | IPC: | C07D239/10, C07D239/22, C07D233/86, C07D233/72, C07D471/10, C07D491/107, C07D249/12, A61K31/4196, A61K31/513, A61K31/4166, A61K31/4188, A61K31/527, A61K9/20, A61K9/48, A61K9/08, A61P35/00 | [2013/22] | CPC: |
C07D233/86 (EP,KR,US);
A61K9/0019 (EP,KR,US);
A61K9/2018 (EP,US);
A61K9/2059 (EP,KR,US);
A61K9/2095 (EP,US);
A61K9/4858 (EP,US);
A61P13/08 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
C07D233/72 (EP,US);
C07D233/74 (KR);
C07D239/10 (EP,US);
C07D239/22 (EP,US);
C07D249/12 (EP,US);
C07D471/10 (EP,US);
C07D491/107 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2013/22] | Title | German: | ZYKLISCHE N,N'-DIARYLTHIOHARNSTOFFE UND N,N'-DIARYLHARNSTOFFE AS ANDROGENREZEPTORANTAGONISTEN, ANTI-KREBSMITTEL DAMIT SOWIE VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG | [2013/22] | English: | CYCLIC N,N'-DIARYLTHIOUREAS AND N,N'-DIARYLUREAS AS ANDROGEN RECEPTOR ANTAGONISTS, ANTI-CANCER AGENT, METHOD FOR PRODUCING AND USING SAME | [2013/22] | French: | N,N'-DIARYLURÉES ET N,N'-DIARYLTHIOURÉES CYCLIQUES, ANTAGONISTES DE RÉCEPTEURS D'ANDROGÈNES, AGENT ANTI-CANCER ET PROCÉDÉ DE PRODUCTION ET D'APPLICATION | [2013/22] | Entry into regional phase | 22.02.2013 | Translation filed | 22.02.2013 | National basic fee paid | 22.02.2013 | Search fee paid | 22.02.2013 | Designation fee(s) paid | 22.02.2013 | Examination fee paid | Examination procedure | 25.01.2012 | Request for preliminary examination filed International Preliminary Examining Authority: RU | 22.02.2013 | Amendment by applicant (claims and/or description) | 22.02.2013 | Examination requested [2013/22] | 07.05.2014 | Application deemed to be withdrawn, date of legal effect [2015/03] | 09.07.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/03] | Divisional application(s) | EP14001526.4 / EP2767531 | Fees paid | Renewal fee | 31.07.2013 | Renewal fee patent year 03 | Penalty fee | Additional fee for renewal fee | 31.07.2014 | 04 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [ ] - No further relevant documents disclosed | International search | [X]WO2006124118 (UNIV CALIFORNIA [US], et al); | [X]WO2007127010 (UNIV CALIFORNIA [US], et al); | [A]RU2152934 (ROUSSEL UCLAF [FR]) | [X] - PRAKASH VISHNU ET AL., "Update on options for treatment of metastatic castration-resistant prostate cancer", ONCO TARGETS AND THERAPY, (2010), vol. 3, pages 39 - 51 | [X] - CA, ACS, Database accession no. 151: 115902 | [ ] - TRAN CHRIS ET AL., "Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer", SCIENCE, (2009), vol. 324, no. 5298, doi:doi:10.1126/science.1168175, pages 787 - 790, XP002696684 DOI: http://dx.doi.org/10.1126/science.1168175 | by applicant | WO2006124118 | WO2007127010 | - DRUG DATA REP., (2009), vol. 31, no. 6, page 609 | - BERGE S.M. ET AL., "Pharmaceutical Salts", J.PHARM.SCI., (1977), vol. 66, doi:doi:10.1002/jps.2600660104, pages 1 - 19, XP002675560 DOI: http://dx.doi.org/10.1002/jps.2600660104 | - CHENG, Y.; PRUSOFF, W. H., "Relationship between the inhibition constant (K;) and the concentration of inhibitor which causes 50 per cent inhibition (IC5o) of an enzymatic reaction", BIOCHEM PHARMACOL., (1973), vol. 22, doi:doi:10.1016/0006-2952(73)90196-2, pages 3099 - 3108, XP001106687 DOI: http://dx.doi.org/10.1016/0006-2952(73)90196-2 |